Mr Eric Schiele > Kirkland & Ellis LLP > New York, United States > Lawyer Profile

Kirkland & Ellis LLP
NEW YORK, NY 10022
United States
Eric Schiele photo

Work Department



Eric Schiele’s practice encompasses M&A and public company board and special committee advisory work, as well as hostile takeover and hedge fund activism defense. Over the course of his career, Eric has advised on announced M&A transactions with an aggregate value of over $950 billion. Corporate clients that Eric has represented include, among others, AbbVie, Amcor, Anheuser-Busch InBev, Bristol-Myers Squibb, Disney, DreamWorks Animation, GlaxoSmithKline, The Washington Post Company, H.J. Heinz, The Heritage Group, Honeywell, IBM, Johnson & Johnson, Northrop Grumman, Taubman Centers, Time Warner, Toll Brothers, Wynn Resorts, Xerox, Yahoo! and Zale Corporation. He also has extensive experience in hedge fund activism defense, including against, among others, Carl Icahn, Elliot Management, Greenlight Capital, Relational, Starboard Value and Trian.


University of Texas School of Law (J.D., with Highest Honors, 2000); Ohio Wesleyan University (B.A., summa cum laude, 1996).

Lawyer Rankings

United States > M&A/corporate and commercial > Shareholder activism

Spread across the firm’s New York, San Francisco, and Houston offices, the team at Kirkland & Ellis LLP is experienced at aiding boards in defending against shareholder activism, particularly activism related to M&A transactions. A key part of the firm’s comprehensive corporate offering, the lawyers focusing on activism defense have broad expertise in all things corporate law, including transactional M&A and private equity deals, and strategic governance and advisory work. In a high-profile case in 2019, the firm advised Bristol-Myers Squibb on activism related to its proposed acquisition of Celgene Corporation, in which opposition to the deal came both from Starboard Value and institutional investor Wellington Management. Key contacts in the New York office include Sarkis Jebejian, Eric Schiele, and Shaun Mathew, David Fox, and Daniel Wolf. The Houston team in particular is a go-to advisor for energy companies facing threats of activist actions; the contact here is Sean Wheeler.

United States > M&A/corporate and commercial > M&A: large deals ($1bn+)

Kirkland & Ellis LLP has a broad transactional practice, acting as lead counsel in public M&A, large-scale and cross-border joint ventures, and contested transactions. Clients of note include Bristol Myers-Squibb, GlaxoSmithKline, and General Motors. Bristol Myers-Squibb in particular provided a key mandate for the practice in the form of its $90bn acquisition of Celgene, a significant transaction within the pharmaceuticals sector led by established ‘outstanding practitionersDaniel Wolf, David Fox, and Jonathan Davis. The team is also active in transactions in the logistics, healthcare, shipping, and manufacturing industries. The firm’s US-wide platform is aided further by strong global connectivity with offices in Europe, Africa, South America, and Asia, enabling it to access ‘great expertise’ from a variety of sources in complex cross-border transactions. The ‘exceptionalEric Schiele is also highly recommended by clients, while Houston-based David Castro and Christopher Heasley are noted for their work in energy sector transactions. All lawyers are in New York unless otherwise stated.